Time: 2024-08-29
SHENZHEN , China , Aug. 18 , 2024 /PRNewswire/ -- Fapon Biotech , a global leader in the In - vitro Diagnostics ( IVD ) industry , is perpetrate to advance global health by supply advanced diagnostic solution . The World Health Organization ( WHO ) declare the monkeypox outbreak as a populace health emergency of International concern ( PHEIC ) on Aug 14 , suggestion Fapon Biotech to supply antigen diagnostic merchandise to address this emerge threat.
Since the 2022 outbreak of monkeypox , Fapon Biotech has been development and upgrade raw material solution for monkeypox antigen rapid trial . The merchandise rich_person high sensitivity , specificity , and show no cross - responsiveness with not - OPXVs like the chickenpox - herpes_zoster virus . These solution are plan to offer more effective and accessible testing option , especially for low- and center - income state and region , facilitate rapid diagnosis in those areas.
In 2023 , the increase global circulation of the monkeypox virus light-emitting_diode to a heighten demand for nosology , emphasizing the need for simplify , automatize , and accessible assay outside lab . WHO stipulate a target merchandise profile for decentralize use , promote More IVD company to develop POCT merchandise for screening and diagnosis in rural environment and area with express healthcare resources.
Fapon Biotech remains perpetrate to leverage its expertness in the ongoing battle against the spread of monkeypox . With over 20 old_age of experience , the company has play a pivotal function in development IVD solution to prevent the spread of infectious disease agent like HIV , hepatitis C , syphilis , malaria , dengue , and respiratory disease . Fapon Biotech base ready to aid global spouse in the development of monkeypox diagnostic rapid trial to combat this global populace health issue.
look to the future , Fapon Biotech 's extensive expertness in antibody design and film_editing - edge technology enable the support of diagnostic trial for earlier detection and treatment to better populace health . The company purpose to deliver earlier , more accurate , convenient , and accessible nosology for everyone , align with their mission of advance global health through advanced solutions.
For those interest in research how Fapon Biotech can aid or collaborate in the battle against monkeypox , they can range out via electronic_mail at [ electronic_mail protect ] The company 's focus on future need and tendency in biotechnology development underscore their committedness to supply global spouse with high - performance IVD reagent raw material , reagent services , and advanced open instrument platform . The attempt make by Fapon Biotech and other IVD company highlight the collaborative approach necessitate to address populace health emergency of International concern like the monkeypox outbreak.
Business
